All news articles for October 2017

The Massachusetts Biotechnology Council was founded in 1985. (Image: Getty/GrandviewGraphics)

Germany-based CRO continues expansion in US

By Melissa Fassbender

KCR has joined the Massachusetts Biotechnology Council – a “must” for the CRO as it continues to strengthen its footprint in the US market, says CEO.

(Image: Getty/serggn)

Study database tribulations stunt trial timelines

By Melissa Fassbender

Clinical study database challenges are delaying clinical trial timelines as CROs and sponsors must manage an increasing variety of trial data, according to a recent study.

GettyImages/eyegelb

Update

Piramal boosts HPAPI site in Michigan, US

By Flora Southey

Piramal Pharma Solutions will expand its high potency active pharmaceutical ingredient (HPAPI) capabilities at its Riverview site in Michigan, US.

(Image: iStock/bedo)

Marken acquires Taiwan-based logistics company

By Melissa Fassbender

Marken has acquired Touchdown International Ltd, a privately held specialty logistics company in Taiwan – a “key market” for pharma production and clinical trials.

GettyImages/Manakin

News In Brief

Avara buys AZ solid dose facility in France

By Flora Southey

Avara Pharmaceutical Services will buy AstraZeneca’s secondary solid dosage form manufacturing, packaging and distribution facility in Reims, France.

GettyImages/dima_sidelnikov

Flexible, agile, niche: How small-sized CROs compete

By Flora Southey

Niche, small-scale CROs can stand their own – despite a predicted increase in consolidation among small-sized contract services firms – says Clinical Trial Consultants (CTC) and data-focused Quanticate.

(Image: iStock/BrianAJackson)

News in Brief

FDA, EMA improving adverse reaction tracking

By Melissa Fassbender

The FDA has launched a new adverse event reporting system and the EMA’s updated EudraVigilance platform is set to go live later this year.